Videoer - Jemperli
SPOTLIGHT Webinar 2025:
Jemperli + chemo in advanced/recurrent pMMR endometrial cancer patients.
Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy
Prof. Kristina Lindemann, MD PhD
Patient Case 1
Stage III pMMR/MSS endometrial cancer
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France
Patient case 2
Stage lll pMMR endometrial cancer
Patient consideration
Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany
Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA
Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and Obstetrics
University of Bielefeld/Klinikum Lippe, Germany
Stage III pMMR/MSS endometrial cancer
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France
Har du spørsmål om JEMPERLI for dine pasienter? Kontakt oss
Jemperli trademark is a registered trademark of the GSK group of companies.
© 2025 GSK group of companies or its licensor.